These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3069099)

  • 21. Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin.
    Malle E; Oettl K; Sattler W; Hoefler G; Kostner GM
    Eur J Clin Invest; 1995 Jan; 25(1):59-67. PubMed ID: 7705389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glyceryl ethers in peroxisomal disease.
    Poulos A; Bankier A; Beckman K; Johnson D; Robertson EF; Sharp P; Sheffield L; Singh H; Usher S; Wise G
    Clin Genet; 1991 Jan; 39(1):13-25. PubMed ID: 1705185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of straight chain and branched chain fatty acid oxidation in skin fibroblasts from patients with peroxisomal disorders.
    Singh H; Usher S; Johnson D; Poulos A
    J Lipid Res; 1990 Feb; 31(2):217-25. PubMed ID: 1691260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase pathway in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin.
    Malle E; Leis HJ; Steinmetz A; Paschke E; Hoefler G
    Clin Chim Acta; 1993 Aug; 217(2):205-12. PubMed ID: 8261630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups.
    Moser AB; Rasmussen M; Naidu S; Watkins PA; McGuinness M; Hajra AK; Chen G; Raymond G; Liu A; Gordon D
    J Pediatr; 1995 Jul; 127(1):13-22. PubMed ID: 7541833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very long-chain fatty acids in peroxisomal disease.
    Poulos A; Beckman K; Johnson DW; Paton BC; Robinson BS; Sharp P; Usher S; Singh H
    Adv Exp Med Biol; 1992; 318():331-40. PubMed ID: 1378993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
    Hoefler G; Hoefler S; Watkins PA; Chen WW; Moser A; Baldwin V; McGillivary B; Charrow J; Friedman JM; Rutledge L
    J Pediatr; 1988 May; 112(5):726-33. PubMed ID: 2452243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peroxisomal disorders; newer concept and recent studies].
    Kamoshita S
    Nihon Rinsho; 1990 Mar; 48(3):629-38. PubMed ID: 2192101
    [No Abstract]   [Full Text] [Related]  

  • 29. Peroxisomal disorders in neurology.
    Wanders RJ; Heymans HS; Schutgens RB; Barth PG; van den Bosch H; Tager JM
    J Neurol Sci; 1988 Dec; 88(1-3):1-39. PubMed ID: 3066850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zellweger-like phenotype in two siblings: a defect in peroxisomal beta-oxidation with elevated very long-chain fatty acids but normal bile acids.
    Mandel H; Berant M; Aizin A; Gershony R; Hemmli S; Schutgens RB; Wanders RJ
    J Inherit Metab Dis; 1992; 15(3):381-4. PubMed ID: 1405475
    [No Abstract]   [Full Text] [Related]  

  • 31. Peroxisomal disorders: a review.
    Wanders RJ; Schutgens RB; Barth PG
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):726-39. PubMed ID: 7545216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chondrodysplasia punctatas and the peroxisomopathies: overlapping syndrome communities.
    Wilson GN; Holmes RD; Hajra AK
    Pathol Immunopathol Res; 1988; 7(1-2):113-8. PubMed ID: 3065763
    [No Abstract]   [Full Text] [Related]  

  • 33. Fatty acid composition of human myelin proteolipid protein in peroxisomal disorders.
    Bizzozero OA; Zuñiga G; Lees MB
    J Neurochem; 1991 Mar; 56(3):872-8. PubMed ID: 1704424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic relationship between the Zellweger syndrome and other peroxisomal disorders characterized by an impairment in the assembly of peroxisomes.
    Tager JM; Brul S; Wiemer EA; Strijland A; Van Driel R; Schutgens RB; Van den Bosch H; Wanders RJ; Westerveld A
    Prog Clin Biol Res; 1990; 321():545-58. PubMed ID: 2183242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids.
    Christensen E; Pedersen SA; Leth H; Jakobs C; Schutgens RB; Wanders RJ
    J Inherit Metab Dis; 1997 Sep; 20(5):658-64. PubMed ID: 9323560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new variant of Zellweger syndrome with normal peroxisomal functions in cultured fibroblasts.
    Schutgens RB; Wanders RJ; Jakobs C; Arslan-Kirchner M; Miller K; Wieacker P; Hunnemann D; Hurter P; von Schutz M
    J Inherit Metab Dis; 1994; 17(3):319-22. PubMed ID: 7807942
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe changes in polyunsaturated fatty acids in the brain, liver, kidney, and retina in patients with peroxisomal disorders.
    Martinez M
    Adv Exp Med Biol; 1992; 318():347-59. PubMed ID: 1636502
    [No Abstract]   [Full Text] [Related]  

  • 38. Correction by gene expression of biochemical abnormalities in fibroblasts from Zellweger patients.
    Shimozawa N; Suzuki Y; Tomatsu S; Tsukamoto T; Osumi T; Fujiki Y; Kamijo K; Hashimoto T; Kondo N; Orii T
    Pediatr Res; 1996 May; 39(5):812-5. PubMed ID: 8726233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complementation analysis of peroxisomal disorders and classical Refsum.
    Poll-The BT; Skjeldal OH; Stokke O; Demaugre F; Saudubray JM
    Prog Clin Biol Res; 1990; 321():537-43. PubMed ID: 1691507
    [No Abstract]   [Full Text] [Related]  

  • 40. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
    Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.